CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 181 enrolled
Drug / intervention
Guideline treatment recommendationsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02896257
NCT02896257N/ACompleted
CompareCT.gov

De-implementing Inhaled Steroids to Improve Care and Safety in COPD (DISCUSS COPD) (QUE 15-471)

VA Office of Research and Development·interventional·Posted Sep 12, 2016·Updated Jul 27, 2023

In Brief

A clinical study evaluating Guideline treatment recommendations for Treatment of Chronic Obstructive Pulmonary Disease. Completed, enrolled 181 participants across 2 sites.

Detailed Summary

This Quality Enhancement Research Initiative (QuERI) project is designed to determine efficacy and acceptance of an intervention method to provide primary care providers with patient-tailored electronic consults and corresponding unsigned orders for de-implementation of inhaled corticosteroids (ICS) for patients with COPD when ICS are not indicated by guidelines.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTreatment of Chronic Obstructive Pulmonary Disease
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 12, 2016
Enrollment StartSep 6, 2016
Primary CompletionJul 29, 2019
Study CompletionJun 30, 2021
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 9.8 years ago

Interventions

Guideline treatment recommendationsother

Patient-tailored E-consult, orders and rationale to discontinue inhaled corticosteroids and discontinue or receive other COPD related care.